GLYCOPREP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glycoprep, and when can generic versions of Glycoprep launch?
Glycoprep is a drug marketed by Goldline and is included in one NDA.
The generic ingredient in GLYCOPREP is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLYCOPREP?
- What are the global sales for GLYCOPREP?
- What is Average Wholesale Price for GLYCOPREP?
Summary for GLYCOPREP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 168 |
| DailyMed Link: | GLYCOPREP at DailyMed |
US Patents and Regulatory Information for GLYCOPREP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Goldline | GLYCOPREP | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SUSPENSION;ORAL | 072319-001 | Dec 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
